Viewing StudyNCT00480753



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00480753
Status: COMPLETED
Last Update Posted: 2007-12-24
First Post: 2007-05-29

Brief Title: Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynauds Phenomenon
Sponsor: MediQuest Therapeutics
Organization: MediQuest Therapeutics

Conditions & Keywords Data

Conditions:
Name
Raynauds Disease
Keywords:
Name View
Raynauds phenomenon secondary to autoimmune disease View
Raynauds phenomenon View
Raynauds Disease View
Raynauds disease secondary to scleroderma View